Synonym
Amilyt; Mytolon; Mytolon chloride; NSC 66373; NSC66373; NSC-66373;
IUPAC/Chemical Name
3,3'-((3,6-dioxocyclohexa-1,4-diene-1,4-diyl)bis(azanediyl))bis(N-benzyl-N,N-diethylpropan-1-aminium) chloride
InChi Key
WQRJZLXQCYZJEU-UHFFFAOYSA-N
InChi Code
InChI=1S/C34H48N4O2.2ClH/c1-5-37(6-2,27-29-17-11-9-12-18-29)23-15-21-35-31-25-34(40)32(26-33(31)39)36-22-16-24-38(7-3,8-4)28-30-19-13-10-14-20-30;;/h9-14,17-20,25-26H,5-8,15-16,21-24,27-28H2,1-4H3;2*1H
SMILES Code
CC[N+](CCCNC1=CC(C(NCCC[N+](CC)(Cc2ccccc2)CC)=CC1=O)=O)(Cc3ccccc3)CC.[Cl-].[Cl-]
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
617.70
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Noël S, Strale PO, Dannhoffer L, Wilke M, DeJonge H, Rogier C, Mettey Y, Becq F. Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr-/- mice. J Cyst Fibros. 2008 Mar;7(2):128-33. doi: 10.1016/j.jcf.2007.06.005. Epub 2007 Sep 4. PMID: 17766192.
2: Bini G, Pugliese AM, Pepeu G, Chelazzi G. Neuronal control of the cardiac responses to osmotic stress in the gastropod limpet Patella caerulea. J Exp Zool A Comp Exp Biol. 2006 Jun 1;305(6):472-9. doi: 10.1002/jez.a.275. PMID: 16646089.
3: Walker RJ, Holden-Dye L, Franks CJ. Physiological and pharmacological studies on annelid and nematode body wall muscle. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Sep;106(1):49-58. doi: 10.1016/0742-8413(93)90253-h. PMID: 7903620.
4: Yeoman MS, Parish DC, Benjamin PR. A cholinergic modulatory interneuron in the feeding system of the snail, Lymnaea. J Neurophysiol. 1993 Jul;70(1):37-50. doi: 10.1152/jn.1993.70.1.37. PMID: 8103088.
5: Christ DD, Blaber LC. The actions of benzoquinonium in the isolated cat tenuissimus muscle. J Pharmacol Exp Ther. 1968 Mar;160(1):159-65. PMID: 4295669.
6: Webb GD. Affinity of benzoquinonium and ambenonium derivatives for the acetylcholine receptor, tested on the electroplax, and for acetylcholinesterase in solution. Biochim Biophys Acta. 1965 May 25;102(1):172-84. doi: 10.1016/0926-6585(65)90211-6. PMID: 5833399.
7: TWAROG BM. The pharmacology of a molluscan smooth muscle. Br J Pharmacol Chemother. 1959 Sep;14(3):404-7. doi: 10.1111/j.1476-5381.1959.tb00266.x. PMID: 13840060; PMCID: PMC1481742.
8: BOWMAN WC. The neuromuscular blocking action of benzoquinonium chloride in the cat and in the hen. Br J Pharmacol Chemother. 1958 Dec;13(4):521-30. doi: 10.1111/j.1476-5381.1958.tb00247.x. PMID: 13618560; PMCID: PMC1481886.
9: HOPPE JO, FUNNELL JE, LAPE H. The effect of structural variation in the quaternary nitrogen centers of benzoquinonium chloride upon neuromuscular blocking activity. J Pharmacol Exp Ther. 1955 Sep;115(1):106-19. PMID: 13264061.
10: FOLDES FF, HUNT RD, CERAVOLO AJ. Use of mytolon chloride with pentothal sodium and nitrous oxide-oxygen for abdominal surgery. Curr Res Anesth Analg. 1952 May-Jun;31(3):185-92. PMID: 14945213.
11: CATTANEO A. Prime esperienze cliniche con un nuovo curaro di sintesi: il mytolon chloride [First clinical experience with a new synthetic curare: mytolon chloride]. G Ital Anestesiol. 1952 Mar-Apr;18(2):193-7. Undetermined Language. PMID: 12980348.
12: ARROWOOD JG. Mytolon chloride: a new agent for producing muscular relaxation; preliminary report. Anesthesiology. 1951 Nov;12(6):753-61. doi: 10.1097/00000542-195111000-00012. PMID: 14885783.
13: FOLDES FF. The use of Mytolon chloride in anesthesiology. Ann N Y Acad Sci. 1951 Oct;54(3):503-11. doi: 10.1111/j.1749-6632.1951.tb39940.x. PMID: 14895078.
14: HOPPE JO. A pharmacological investigation of 2,5-bis-(3-diethylaminopropylamino) benzoquinone-bis-benzylchloride (WIN 2747): a new curarimimetic drug. J Pharmacol Exp Ther. 1950 Nov;100(3):333-45. PMID: 14795391.